A role for TRPV1 in agonist-evoked activation of human platelets

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 2, 2009, Pages 330-338

  Harper, A G S ^a   Brownlow, S L ^a   Sage, Stewart O ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

5 iodo resiniferatoxin; 5 HT; AMG 9810; Inflammation; Platelet; TRPV1

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; BENZOFURAN DERIVATIVE; CAPSAICIN; FURA 2; KETANSERIN; LUCIFERASE; LUCIFERIN; PHTHALALDEHYDE; RECEPTOR ANTIBODY; RESINIFERATOXIN; SEROTONIN; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 1 RECEPTOR ANTIBODY;

ANTIBODY SPECIFICITY; ARTICLE; ATHEROSCLEROSIS; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL STIMULATION; CONTROLLED STUDY; FLUORESCENCE; HUMAN; HUMAN CELL; INFLAMMATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SEROTONIN RELEASE; SODIUM CELL LEVEL; THROMBOCYTE ACTIVATION; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATE; BLOOD PLATELETS; CALCIUM; CYTOSOL; HUMANS; PLATELET ACTIVATION; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN; SODIUM; TRPV CATION CHANNELS;

EID: 59049083018     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2008.03231.x     Document Type: Article

References (28)

1. Huo Y, Ley KF. Role of platelets in the development of atherosclerosis. Trends Cardiovasc Med 2004; 14: 18-22.
2. Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol Rev 2007; 87: 165-217.
3. Hassock SR, Zhu MX, Trost C, Flockerzi V, Authi KS. Expression and role of TRPC proteins in human platelets: Evidence that TRPC6 forms the store-independent calcium entry channel. Blood 2002; 100: 2801-11.
4. Brownlow SL, Sage SO. Transient receptor potential protein subunit assembly and membrane distribution in human platelets. Thromb Haemost 2005; 94: 839-45.
5. Miller BA. The role of TRP channels in oxidative stress-induced cell death. J Membr Biol 2006; 209: 31-41.
6. Bugert P, Kluter H. Profiling of gene transcripts in human platelets: An update of the platelet transcriptome. Platelets 2006; 17: 503-4.
7. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-50.
8. de Leiva A, Schwartz S. Relation of pH to fluorescence of serotonin, melatonin and other indole compounds reacted with o-phthaldialdehyde. Clin Chem 1976; 22: 1999-2005.
9. Caterina MJ, Rosen TA, Tominaga M, Brake AJ, Julius D. A capsaicin-receptor homologue with a high threshold for noxious heat. Nature 1999; 398: 436-41.
10. Wahl P, Foged C, Tullin S, Thomsen C. 5-Iodoresiniferatoxin evokes hypothermia in mice and is a partial transient receptor potential vanilloid 1 agonist in vitro. Mol Pharmacol 2001; 59: 9-15.
11. Gavva NR, Tamir R, Qu Y, Klionsky L, Zhang TJ, Immke D, Wang J, Zhu D, Vanderah TW, Porreca F, Doherty EM, Norman MH, Wild KD, Bannon AW, Louis J-C, Treanor JJS. AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. J Pharmacol Exp Ther 2005; 313: 474-84.
12. 2+ stores in the dorsal root ganglion cells of adult rats. Biochem Biophys Res Commun 2001; 285: 1114-20.
13. 2+ by vanilloid receptor I in rat dorsal root ganglion neurons. J Biol Chem 2003; 278: 5462-72.
14. + concentration increase in human platelets. Cell Physiol Biochem 2004; 14: 377-86.
15. Rudnick G. Active transport of 5-hydroxytryptamine by plasma membrane vesicles isolated from human blood platelets. J Biol Chem 1977; 252: 2170-4.
16. Yáñez M, Fraiz N, Cano E, Orallo F. Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity. Biochem Biophys Res Commun 2006; 344: 688-95.
17. Caterina MJ, Julius D. The vanilloid receptor: A molecular gateway to the pain pathway. Annu Rev Neurosci 2001; 24: 487-517.
18. Staurowicz K, Nigam S, Di Marzo V. Biochemistry and pharmacology of endovanilloids. Pharmacol Ther 2007; 114: 13-33.
19. Treiber K, Singer A, Henke B, Muller WE. Hyperforin activates non-selective cation channels (NSCCs). Br J Pharmacol 2005; 145: 75-83.
20. Uebelhack R, Franke L. In vitro effects of St. John's wort extract and hyperforin on 5 HT uptake and efflux in human blood platelets. Pharmacopsychiatry 2001; 34 (Suppl. 1): S146-7.
21. van der Stelt M, Di Marzo V. Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels. Eur J Biochem 2004; 271: 1827-34.
22. McHugh D, McMaster RS, Perwee RG, Roy S, Mahadevan A, Razdan RK, Ross RA. Novel compounds that interact with both leukotriene B4 receptors and vanilloid TRPV1 receptors. J Pharmacol Exp Ther 2006; 316: 955-65.
23. Maccarrone M, Bari M, Menichelli A, Del Principe D, Agrò AF. Anandamide activates human platelets through a pathway independent of the arachidonate cascade. FEBS Lett 1999; 447: 277-82.
24. Calzada C, Véricel E, Lagarde M. Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation. Biochem J 1997; 325: 495-500.
25. Calzada C, Véricel E, Mitel B, Coulon L, Lagarde M. 12(S)-Hydroperoxy-eicosatetraenoic acid increases arachidonic acid availability in collagen-primed platelets. J Lipid Res 2001; 42: 1467-73.
26. Chuang H-H, Prescott ED, Kong H, Shields S, Jordt SE, Basbaum AI, Chao MV, Julius D. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 2001; 411: 957-62.
27. Henriksson P, Hamberg M, Diczfalusy U. Formation of 15-HETE as a major hydroxyeicosatetraenoic acid in the atherosclerotic vessel wall. Biochim Biophys Acta 1985; 834: 272-4.
28. Yoshimoto T, Takahasi Y. Arachidonate 12-lipoxygenases. Prostaglandins Other Lipid Mediat 2002; 68-69: 245-62.